Creating tools to better understand tuberculosis bacteria
Generation of a Complete Set of Precise Null Bar-Coded Deletion Mutants of Mycobacterium tuberculosis
This project is making special versions of tuberculosis bacteria to help scientists find new ways to fight this serious infection.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albert Einstein College of Medicine NIH-funded |
| Lab location | 1 site (Bronx, United States) |
| Project ID | NIH-11137748 on NIH RePORTER |
What this research studies
Tuberculosis (TB) remains a significant global health challenge, especially with the rise of drug-resistant strains and its connection to HIV. To develop better diagnostics, vaccines, and treatments, we need a deeper understanding of how the TB bacteria work and interact with the human body. This project aims to speed up TB discoveries by creating a complete collection of 4,000 unique, bar-coded versions of the TB bacteria. These tools will be shared with researchers worldwide to help them study every gene in the bacteria.
Who could benefit from this research
Good fit: This foundational research does not directly involve patients, but future studies stemming from this work would benefit individuals with tuberculosis, especially those with drug-resistant forms.
Not a fit: Patients not affected by tuberculosis or related conditions would not directly benefit from this specific research project.
Why it matters
Potential benefit: If successful, this work could accelerate the discovery of new drugs, vaccines, and diagnostic tests for tuberculosis, ultimately leading to better patient outcomes.
How similar studies have performed: While the creation of such a comprehensive and precise set of bar-coded mutants is a novel and large-scale undertaking, similar genetic manipulation techniques have proven successful in understanding other bacterial pathogens.
Where this research is happening
Bronx, United States
- Albert Einstein College of Medicine — Bronx, United States (Active)
Researchers
- Principal investigator: Jacobs, William Robert — Albert Einstein College of Medicine
- Study coordinator: Jacobs, William Robert
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.